Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Multispecific Antibody Development Platform Based on Human Heavy Chain Antibodies.

Clarke SC, Ma B, Trinklein ND, Schellenberger U, Osborn MJ, Ouisse LH, Boudreau A, Davison LM, Harris KE, Ugamraj HS, Balasubramani A, Dang KH, Jorgensen B, Ogana HAN, Pham DT, Pratap PP, Sankaran P, Anegon I, van Schooten WC, Brüggemann M, Buelow R, Force Aldred S.

Front Immunol. 2019 Jan 7;9:3037. doi: 10.3389/fimmu.2018.03037. eCollection 2018.

2.

Breakdown of Immune Tolerance in AIRE-Deficient Rats Induces a Severe Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy-like Autoimmune Disease.

Ossart J, Moreau A, Autrusseau E, Ménoret S, Martin JC, Besnard M, Ouisse LH, Tesson L, Flippe L, Kisand K, Peterson P, Hubert FX, Anegon I, Josien R, Guillonneau C.

J Immunol. 2018 Aug 1;201(3):874-887. doi: 10.4049/jimmunol.1701318. Epub 2018 Jun 29.

PMID:
29959280
3.

Generation of Immunodeficient Rats With Rag1 and Il2rg Gene Deletions and Human Tissue Grafting Models.

Ménoret S, Ouisse LH, Tesson L, Delbos F, Garnier D, Remy S, Usal C, Concordet JP, Giovannangeli C, Chenouard V, Brusselle L, Merieau E, Nerrière-Daguin V, Duteille F, Bellier-Waast F, Fraichard A, Nguyen TH, Anegon I.

Transplantation. 2018 Aug;102(8):1271-1278. doi: 10.1097/TP.0000000000002251.

PMID:
29688994
4.

Advances in transgenic animal models and techniques.

Ménoret S, Tesson L, Remy S, Usal C, Ouisse LH, Brusselle L, Chenouard V, Anegon I.

Transgenic Res. 2017 Oct;26(5):703-708. doi: 10.1007/s11248-017-0038-x. Epub 2017 Aug 5.

PMID:
28780744
5.

Antigen-specific single B cell sorting and expression-cloning from immunoglobulin humanized rats: a rapid and versatile method for the generation of high affinity and discriminative human monoclonal antibodies.

Ouisse LH, Gautreau-Rolland L, Devilder MC, Osborn M, Moyon M, Visentin J, Halary F, Bruggemann M, Buelow R, Anegon I, Saulquin X.

BMC Biotechnol. 2017 Jan 9;17(1):3. doi: 10.1186/s12896-016-0322-5.

6.

Comparative Analysis of piggyBac, CRISPR/Cas9 and TALEN Mediated BAC Transgenesis in the Zygote for the Generation of Humanized SIRPA Rats.

Jung CJ, Ménoret S, Brusselle L, Tesson L, Usal C, Chenouard V, Remy S, Ouisse LH, Poirier N, Vanhove B, de Jong PJ, Anegon I.

Sci Rep. 2016 Aug 17;6:31455. doi: 10.1038/srep31455.

7.

A Rapid and Cost-Effective Method for Genotyping Genome-Edited Animals: A Heteroduplex Mobility Assay Using Microfluidic Capillary Electrophoresis.

Chenouard V, Brusselle L, Heslan JM, Remy S, Ménoret S, Usal C, Ouisse LH, NGuyen TH, Anegon I, Tesson L.

J Genet Genomics. 2016 May 20;43(5):341-8. doi: 10.1016/j.jgg.2016.04.005. Epub 2016 May 4.

PMID:
27209567
8.

Transgenic animals and genetic engineering techniques. Nantes, France, 2-3 July, 2015.

Ménoret S, Tesson L, Remy S, Usal C, Ouisse LH, Brusselle L, Chenouard V, Nguyen TH, David L, Anegon I.

Transgenic Res. 2015 Dec;24(6):1079-85. doi: 10.1007/s11248-015-9904-6. Epub 2015 Sep 10. No abstract available.

PMID:
26358113
9.

Gene targeting in rats using transcription activator-like effector nucleases.

Ménoret S, Tesson L, Rémy S, Usal C, Thépenier V, Thinard R, Ouisse LH, De Cian A, Giovannangeli C, Concordet JP, Anegon I.

Methods. 2014 Aug 15;69(1):102-7. doi: 10.1016/j.ymeth.2014.02.027. Epub 2014 Feb 28.

PMID:
24583114
10.

Human antibody expression in transgenic rats: comparison of chimeric IgH loci with human VH, D and JH but bearing different rat C-gene regions.

Ma B, Osborn MJ, Avis S, Ouisse LH, Ménoret S, Anegon I, Buelow R, Brüggemann M.

J Immunol Methods. 2013 Dec 31;400-401:78-86. doi: 10.1016/j.jim.2013.10.007. Epub 2013 Oct 30.

11.

Technical advances in the generation of transgenic animals and in their applications. Nantes, France, June 7th 2013.

Ménoret S, Tesson L, Rémy S, Thinard R, Usal C, Ouisse LH, Thepenier V, Anegon I.

Transgenic Res. 2013 Oct;22(5):1065-72. doi: 10.1007/s11248-013-9736-1. Epub 2013 Aug 2. No abstract available.

PMID:
23907705
12.

Adrenal gland infection by serotype 5 adenovirus requires coagulation factors.

Tran L, Ouisse LH, Richard-Fiardo P, Franken PR, Darcourt J, Cornilleau G, Benihoud K, Vassaux G.

PLoS One. 2013 Apr 25;8(4):e62191. doi: 10.1371/journal.pone.0062191. Print 2013.

13.

High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region.

Osborn MJ, Ma B, Avis S, Binnie A, Dilley J, Yang X, Lindquist K, Ménoret S, Iscache AL, Ouisse LH, Rajpal A, Anegon I, Neuberger MS, Buelow R, Brüggemann M.

J Immunol. 2013 Feb 15;190(4):1481-90. doi: 10.4049/jimmunol.1203041. Epub 2013 Jan 9. Erratum in: J Immunol. 2013 Jun 15;190(12):6707.

14.

Generation of Rag1-knockout immunodeficient rats and mice using engineered meganucleases.

Ménoret S, Fontanière S, Jantz D, Tesson L, Thinard R, Rémy S, Usal C, Ouisse LH, Fraichard A, Anegon I.

FASEB J. 2013 Feb;27(2):703-11. doi: 10.1096/fj.12-219907. Epub 2012 Nov 12.

PMID:
23150522
15.

Early Treg suppression by a listeriolysin-O-expressing E. coli vaccine in heterologous prime-boost vaccination against cancer.

Dai MS, Vassaux G, Xu M, You RI, Hsieh YF, Ouisse LH, Lo KY, Sytwu HK, Chao TY.

Vaccine. 2012 Nov 6;30(48):6903-11. doi: 10.1016/j.vaccine.2012.09.001. Epub 2012 Sep 14.

PMID:
22982404
16.

Tumor-reactive CD4+ CD8αβ+ CD103+ αβT cells: a prevalent tumor-reactive T-cell subset in metastatic colorectal cancers.

Sarrabayrouse G, Corvaisier M, Ouisse LH, Bossard C, Le Mével B, Potiron L, Meurette G, Gervois N, Jotereau F.

Int J Cancer. 2011 Jun 15;128(12):2923-32. doi: 10.1002/ijc.25640. Epub 2010 Dec 1.

17.

A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes.

Larrieu P, Ouisse LH, Guilloux Y, Jotereau F, Fonteneau JF.

Cancer Immunol Immunother. 2007 Oct;56(10):1565-75. Epub 2007 Feb 23.

PMID:
17318652

Supplemental Content

Loading ...
Support Center